AI Summary
This article discusses the potential role of GLP-1 receptor agonists in neurology and psychiatry, exploring their effects on conditions such as stroke, addiction, and Parkinson’s disease. Neurologist Christoph Diener reviews the current evidence on the use of GLP-1s in these fields.
Neurologist Christoph Diener discusses the evidence to date on GLP-1 receptor agonists in stroke, addiction, Parkinson’s disease, and beyond.
Medscape Neurology